Immunogen | Passivo Circulante



Passivo Circulante Alterar Data
AbbVie USD 39.39B 376M 2025-09
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Astellas Pharma JPY 1.32T 873M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Exelixis USD 405.64M 31.86M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Heron Therapeutics USD 89.71M 168.89M 2025-09
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
MacroGenics USD 44.47M 5.47M 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 9.32B 2025-12


Immunogen Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.